![](https://investorshub.advfn.com/uicon/113775.png?cb=1640546002)
Sunday, January 25, 2015 12:19:27 PM
SEC filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001355790&owner=include&count=40
OTCQB: http://www.otcmarkets.com/stock/ISCO/quote
Press Releases: http://www.internationalstemcell.com/Press_Releases
Recent News: http://finance.yahoo.com/q/h?s=ISCO+Headlines
They are expecting to file an IND for Parkinson’s disease soon. The plan is to hold the trial in Australia. They expect the trial time to be cut in half with this change in venue.
Having two subsidiaries bringing in revenues to offset the need for dilution while working on therapies is an excellent thing. Plus, one or both of the subsidiaries could end up huge down the road. I really like the way they have set themselves up for future growth. As with any stock in this sector, there are still risks. I only invest that which I can afford to lose. However, they are very unusual since most don't have any revenues at this stage of development.
From the ISCO website: http://www.b2i.us/profiles/investor/fullpage.asp?BzID=1468&to=cp&Nav=0&LangID=1&s=396&ID=14259
Business Model
International Stem Cell Corporation (ISCO) operates under a novel business model for the biotechnology industry. This model comprises subsidiary business units that generate revenue from the sale of products developed from scientific discoveries made by ISCO. Not only is this model self-sustaining with the revenues used to support further scientific research and development, but it also provides practical, short-term applications of the core technologies.
Therapeutic Programs
http://www.internationalstemcell.com/Therapeutic_Programs
Lifeline Skin Care (LSC)
http://www.lifelineskincare.com/
Lifeline Cell Technology (LCT)
http://www.lifelinecelltech.com/
Intellectual Property
http://www.internationalstemcell.com/Intellectual_Property
Scientific Publications
http://www.internationalstemcell.com/Scientific_Publications
Management: http://www.internationalstemcell.com/Management
Company Address:
Corporate Headquarters
5950 Priestly Drive
Carlsbad, CA 92008
Phone: +1-760-940-6383
Fax: +1-760-476-0600
~~~~~~~~~~
A potential negative for early investors is the upcoming reverse split.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent ISCO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:05:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:00:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 06:18:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 06:17:20 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/27/2023 04:27:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 12:01:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 06:20:54 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM